InvestorsHub Logo
Followers 58
Posts 10034
Boards Moderated 1
Alias Born 09/21/2016

Re: RedShoulder post# 360149

Thursday, 05/12/2022 10:52:31 AM

Thursday, May 12, 2022 10:52:31 AM

Post# of 458274
RedShoulder

I'm expecting to see a PR saying the Alzheimer trial has completed and is closed sometime before the end of 'this month' and this month is almost half over. That should get wide news coverage in the financial sections and move/push the SP into higher trading levels,

As we are well aware on this MB, Anavex has been unfairly overlooked in articles on Alzheimer in the past time after time, but that is about to change in a big way as it will show AVXL in the clear leader in that space with the potentially pivotal AD Ph-2b/3 trial completed, and now just waiting on the TLDR in Sept or Oct.

Leaks coming out on Australia says patients are getting much better. No Alzheimer drug has ever accomplished what AVXL did in Ph-2 and by all leaked accounts is doing it again - reversing the disease.

Be prepared, the CEO said he would announce that the trial has completed and is closed.



Thanks for your insightful and positive assessment. Sad that we must only deal w/leaks but...I'll take them as credible . I do admire and respect the Australian culture and value systems as credible. All the best...feel free to leak here at any time .
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News